These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16840393)

  • 1. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study.
    Kessler R; Ståhl E; Vogelmeier C; Haughney J; Trudeau E; Löfdahl CG; Partridge MR
    Chest; 2006 Jul; 130(1):133-42. PubMed ID: 16840393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].
    Jiang M; Ma JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day-to-day living with severe chronic obstructive pulmonary disease: towards a family-based approach to the illness impacts.
    Gabriel R; Figueiredo D; Jácome C; Cruz J; Marques A
    Psychol Health; 2014; 29(8):967-83. PubMed ID: 24617821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient's perception of exacerbations of COPD--the PERCEIVE study.
    Miravitlles M; Anzueto A; Legnani D; Forstmeier L; Fargel M
    Respir Med; 2007 Mar; 101(3):453-60. PubMed ID: 16938447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.
    Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K
    Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease.
    Wilkinson TM; Donaldson GC; Hurst JR; Seemungal TA; Wedzicha JA
    Am J Respir Crit Care Med; 2004 Jun; 169(12):1298-303. PubMed ID: 14990395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.
    Miravitlles M; Anzueto A; Ewig S; Legnani D; Stauch K
    Ther Adv Respir Dis; 2009 Dec; 3(6):267-77. PubMed ID: 19880426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patient' s perspective of chronic obstructive pulmonary disease in Yanqing county of Beijing].
    Shen N; Yao WZ; Zhu H
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Mar; 31(3):206-8. PubMed ID: 18785520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
    Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD
    Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year.
    Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Wang C; Bourbeau J
    Eur Respir J; 2010 May; 35(5):1022-30. PubMed ID: 19897555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom variability in patients with severe COPD: a pan-European cross-sectional study.
    Kessler R; Partridge MR; Miravitlles M; Cazzola M; Vogelmeier C; Leynaud D; Ostinelli J
    Eur Respir J; 2011 Feb; 37(2):264-72. PubMed ID: 21115606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real world COPD: association of morning symptoms with clinical and patient reported outcomes.
    Roche N; Small M; Broomfield S; Higgins V; Pollard R
    COPD; 2013 Dec; 10(6):679-86. PubMed ID: 24127914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-traumatic stress symptoms and exacerbations in COPD patients.
    Teixeira PJ; Porto L; Kristensen CH; Santos AH; Menna-Barreto SS; Do Prado-Lima PA
    COPD; 2015 Feb; 12(1):90-5. PubMed ID: 24983958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis.
    Yu AP; Yang H; Wu EQ; Setyawan J; Mocarski M; Blum S
    J Med Econ; 2011; 14(3):315-23. PubMed ID: 21500975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
    Seemungal TA; Donaldson GC; Paul EA; Bestall JC; Jeffries DJ; Wedzicha JA
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1418-22. PubMed ID: 9603117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing exacerbation-related self-management in patients with COPD: a qualitative study.
    Korpershoek Y; Vervoort S; Nijssen L; Trappenburg J; Schuurmans MJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2977-2990. PubMed ID: 27932877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare.
    Llor C; Molina J; Naberan K; Cots JM; Ros F; Miravitlles M;
    Int J Clin Pract; 2008 Apr; 62(4):585-92. PubMed ID: 18266710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
    Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
    Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we identify patients with different illness schema following an acute exacerbation of COPD: a cluster analysis.
    Harrison SL; Robertson N; Graham CD; Williams J; Steiner MC; Morgan MD; Singh SJ
    Respir Med; 2014 Feb; 108(2):319-28. PubMed ID: 24238773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.